SFY 2020 - 2021 MC BHET Report Summary
HIV SNP line of business
- Document also available in Portable Document Format (PDF)
| Plan | BHET % | BHET Target Expense | BHET Experience | Remittance | MMs | |
|---|---|---|---|---|---|---|
| Amida Care Inc. | 98.67% | $16,228,897 | $16,013,502 | $0 | 76,205 | |
| MetroPlus Health Plan, Inc | 63.45% | $9,003,690 | $5,712,988 | $2,930,554 | 42,260 | |
| VNS (d/b/a VNSNY Choice) and Subsidiary | 86.24% | $7,662,017 | $6,607,693 | $747,843 | 33,418 | |
| Total | $32,894,604 | $28,334,183 | $3,678,397 | 151,883 |
NOTES:
BHET Target 96%
